The present disclosure relates to a pharmaceutical composition for preventing or treating a cranial nerve disease, comprising a Fomes fomentarius extract, a fraction thereof, or a compound isolated therefrom as an active ingredient. According to the present disclosure, the Fomes fomentarius extract is included as an active ingredient so that there are significant effects of inhibiting the production or expression of inflammatory cytokines and improving the activity of glucose metabolism in the brain to prevent or treat cranial nerve diseases, of lowering side effects on the human body as a natural product, and of being easily prepared and ingested.

The present disclosure relates to a pharmaceutical composition for preventing or treating a cranial nerve disease, comprising a Fomes fomentarius extract, a fraction thereof, or a compound isolated therefrom as an active ingredient. According to the present disclosure, the Fomes fomentarius extract is included as an active ingredient so that there are significant effects of inhibiting the production or expression of inflammatory cytokines and improving the activity of glucose metabolism in the brain to prevent or treat cranial nerve diseases, of lowering side effects on the human body as a natural product, and of being easily prepared and ingested.

The present disclosure relates to a pharmaceutical composition for preventing or treating a cranial nerve disease, comprising a Fomes fomentarius extract, a fraction thereof, or a compound isolated therefrom as an active ingredient. According to the present disclosure, the Fomes fomentarius extract is included as an active ingredient so that there are significant effects of inhibiting the production or expression of inflammatory cytokines and improving the activity of glucose metabolism in the brain to prevent or treat cranial nerve diseases, of lowering side effects on the human body as a natural product, and of being easily prepared and ingested.

The present document describes a nutriprotective diet comprising a nutriprotective amount of a sugar plant syrup, a sugar plant syrup extract, a sugar plant extract, or combinations thereof. The present document also describes a method of eliciting a nutriprotective effect in a subject, which comprises administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document also describes a method of treating a subject with a disorder, by administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document describes a process for the extraction of polyphenolic compounds from maple syrup using adsorbent materials, and the extracts obtained therefrom.

The present document describes a nutriprotective diet comprising a nutriprotective amount of a sugar plant syrup, a sugar plant syrup extract, a sugar plant extract, or combinations thereof. The present document also describes a method of eliciting a nutriprotective effect in a subject, which comprises administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document also describes a method of treating a subject with a disorder, by administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document describes a process for the extraction of polyphenolic compounds from maple syrup using adsorbent materials, and the extracts obtained therefrom.

Provided is a pharmaceutical composition including quercetin-3-O-β-D-xylopyranoside for preventing or treating a liver disease. Since the composition has an effect on inhibiting alcohol-induced accumulation of triglycerides in the blood and liver, having no toxicity and without affecting feed intake, body weight, organ weight, and the like, the composition of the present invention may be efficiently utilized as a pharmaceutical composition for preventing and treating a liver disease such as steatosis, hepatitis, hepatic fibrosis, and cirrhosis or a health functional food for preventing or alleviating a liver disease such as steatosis, hepatitis, hepatic fibrosis, and cirrhosis.

There is provided herein antibacterial products and processes for preparing antibacterial products from maple syrup and passivating agents in the presence of a catalyst under irradiation or hydrothermal reaction conditions. The disclosure further provides a method for inhibiting the growth of a gram-positive bacteria, a gram-negative bacteria or a yeast.

The present invention relates to a maple syrup product having a low water content. The maple syrup product retains the physical and palatable properties of untreated maple syrup while having a prolonged shelf-life. It can be advantageously used to sweeten beverages (such as hot beverages) and in the manufacture of pharmaceutical compositions (such as throat lozenges) and/or confectionery.

The present invention relates to a maple syrup product having a low water content. The maple syrup product retains the physical and palatable properties of untreated maple syrup while having a prolonged shelf-life. It can be advantageously used to sweeten beverages (such as hot beverages) and in the manufacture of pharmaceutical compositions (such as throat lozenges) and/or confectionery.

Provided is a method of producing mineral function water showing beneficial effects, such as antioxidant effects, or the like. The water including contains mineral-containing water (A) and mineral-containing water (B) according to a ratio of 1:5 to 1:20 (weight ratio), the mineral-containing water (A) containing first mineral components eluted from mineral-imparting material (A) containing: vegetation raw material, woody plant raw material, and sulfur raw material, the mineral-containing water (B) containing second mineral-containing water (B) containing the mineral component eluted from inorganic mineral-imparting material (B).